ANIP logo
ANI Pharmaceuticals, Inc.(ANIP)
Last print unknown agoAbout this dataData status
$72.56▲0.27 (0.37%)Stale · unknown old

ANIP Stock-Based Compensation

$41.06MTTM · USD

Period ending:

ANIP FY Stock-Based CompUSD
ANIP FY Stock-Based Comp1998-12-31: $0.001999-12-31: $0.002000-12-31: $0.002001-12-31: $18.00K2002-12-31: $18.00K2003-12-31: $193.00K2004-12-31: $572.54K2005-12-31: $351.50M2006-12-31: $0.002007-12-31: $0.002008-12-31: $1.10M2009-12-31: $1.25M2010-12-31: $992.76K2011-12-31: $1.18M2012-12-31: $725.63K2013-12-31: $4.45M2014-12-31: $3.42M2015-12-31: $3.86M2016-12-31: $6.07M2017-12-31: $6.09M2018-12-31: $6.78M2019-12-31: $9.22M2020-12-31: $12.94M2021-12-31: $10.49M2022-12-31: $14.60M2023-12-31: $20.65M2024-12-31: $29.34M2025-12-31: $37.93M$351.50M$0.00
1998-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

ANIP stock-based compensation history

Non-cash compensation expense paid in equity. The available annual fiscal periods series contains 28 observations from Dec 31, 1998 to Dec 31, 2025.

Ani Pharmaceuticals Inc Stock-Based Compensation — Annual fiscal periods (USD)
Period endingStock-Based Compensation (USD)
37,929,000
29,344,000
20,652,000
14,599,000
10,489,000
12,936,000
9,217,000
6,782,000
6,090,000
6,067,000
3,856,000
3,423,000
4,454,000
725,625
1,177,683
992,757
1,254,503
1,102,444
0
0
351,500,000
572,541
193,000
18,000
18,000
0
0
0

Compare stock-based compensation

All ANIP financial metrics · ANIP stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.